INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)

About INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)

Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on SUBA-Itraconazole, a patented, oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.

INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. News